<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04919798</url>
  </required_header>
  <id_info>
    <org_study_id>CIP_NIBED_V1-8</org_study_id>
    <nct_id>NCT04919798</nct_id>
  </id_info>
  <brief_title>First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study</brief_title>
  <acronym>NIBED pilot</acronym>
  <official_title>Randomized, Controlled, Cross-over, First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ecole Polytechnique Fédérale de Lausanne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The non-invasive bladder emptying device (NIBED) is a handheld medical device that is applied&#xD;
      to the penis during urinating to aid bladder emptying in urinary retention patients with&#xD;
      increased residual urine volume.&#xD;
&#xD;
      This pilot study primarily seeks to determine the safety of the NIBED. Secondary objectives&#xD;
      are to assess the efficacy of the NIBED, which is defined as the ability of the medical&#xD;
      device to aid or improve bladder emptying, i.e. leads to less residual urine compared to not&#xD;
      using the NIBED.&#xD;
&#xD;
      During the intervention, the study participant will urinate with and without the NIBED.&#xD;
      Safety variables such as penile pain, penile lesions and hematuria will be recorded. Efficacy&#xD;
      will be assessed by measuring voided volume, residual volume, voiding time and urine flow&#xD;
      rate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 26, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Penile pain</measure>
    <time_frame>7 days</time_frame>
    <description>Assessment of penile pain (reported as numeric pain rating scale (NPRS): 0 (no pain at all) to 10 (worst imaginable pain))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Penile lesions</measure>
    <time_frame>7 days</time_frame>
    <description>Assessment of penile lesions (visually assessed and reported as numeric rating scale (NRS): 0 (none) to 5 (exposed urethra))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematuria</measure>
    <time_frame>7 days</time_frame>
    <description>Assessment of hematuria (dipstick urinalysis, scale: negative, 1+, 2+, 3+, 4+, macrohematuria (visible))</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with adverse events of special interest (AESI)</measure>
    <time_frame>7 days</time_frame>
    <description>Number of patients with adverse events of special interest (AESI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Voided urine volume</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment of voided urine volume, measured by uroflowmeter/scale [ml]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual volume</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment of residual volume, measured with ultrasound bladder scanner [ml]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voiding time</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment of voiding time, measured with clock [s]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine flow rate</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment of urine flow rate, measured with uroflowmeter [ml/s]</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Usability of the device</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment of usability and device acceptance, measured with a patient questionnaire (multiple choice questions and likert scale)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Urinary Retention</condition>
  <arm_group>
    <arm_group_label>Urinating with NIBED first, without NIBED second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Urinating with NIBED first, without NIBED second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Urinating without NIBED first, with NIBED second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Urinating without NIBED first, with NIBED second</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive bladder emptying device</intervention_name>
    <description>The NIBED is applied to the penis during urination to support bladder emptying in urinary retention patients. It is a battery-driven handheld device that is operated by the patient himself.</description>
    <arm_group_label>Urinating with NIBED first, without NIBED second</arm_group_label>
    <arm_group_label>Urinating without NIBED first, with NIBED second</arm_group_label>
    <other_name>NIBED</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed Consent as documented by signature&#xD;
&#xD;
          -  Age 18 years or older&#xD;
&#xD;
          -  Sex: male&#xD;
&#xD;
          -  Diagnosed with underactive bladder (UAB) (confirmed with urodynamic testing)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute urinary tract infection&#xD;
&#xD;
          -  Patients on anti-coagulants (exception Aspirin)&#xD;
&#xD;
          -  Penile pain (NPRS score &gt;2)&#xD;
&#xD;
          -  Pain during voiding (NPRS &gt;2)&#xD;
&#xD;
          -  Penile lesions (NRS score &gt;2)&#xD;
&#xD;
          -  Hematuria &gt;2+&#xD;
&#xD;
          -  Mechanical subvesical obstruction (confirmed by cystoscopy) (exception BPO)&#xD;
&#xD;
          -  Transurethral resection of the prostate (TURP) less than three months before visit 2&#xD;
&#xD;
          -  Penile abnormalities (Buried penis, Peyronie's disease, skin lesions)&#xD;
&#xD;
          -  Asensitive bladder (no sensation of bladder fullness)&#xD;
&#xD;
          -  Shy bladder&#xD;
&#xD;
          -  Indwelling transurethral catheter&#xD;
&#xD;
          -  Inability to understand and follow the study protocol&#xD;
&#xD;
          -  Previous enrolment into the current study&#xD;
&#xD;
          -  Enrolment of the investigator, his/her family members, employees and other dependent&#xD;
             persons&#xD;
&#xD;
          -  Participation in another interventional clinical trial within 3 months prior to visit&#xD;
             2 or planned participation during the trial&#xD;
&#xD;
          -  Lacking capacity for consent&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Kiss</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fiona Burkhard</last_name>
    <phone>+41 31 632 36 41</phone>
    <email>fiona.burkhard@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bern University Hospital Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Kiss</last_name>
      <phone>+41 76 228 39 08</phone>
      <email>bernhard.kiss@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medical device</keyword>
  <keyword>Bladder emptying</keyword>
  <keyword>Underactive bladder</keyword>
  <keyword>Benign prostatic obstruction</keyword>
  <keyword>Residual urine</keyword>
  <keyword>Non-invasive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

